Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMO | O15229 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TNF | P01375 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2168338 | 0.91 | CYP1A2 (0.43) | MAPTALOX15SMN1; SMN2KDM4EKMO | |
| SCHEMBL2169199 | 0.89 | KDM4E (0.42) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL2170758 | 0.86 | CYP1A2 (0.39) | MAPTALOX15SMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL2169248 | 0.84 | KDM4E (0.48) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7858314 | 0.84 | KDM4E (0.48) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7861210 | 0.84 | KDM4E (0.48) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7849174 | 0.83 | KMT2A (0.36) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL29771892 | 0.82 | ALDH1A1 (0.41) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7850416 | 0.82 | ALDH1A1 (0.41) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7857231 | 0.82 | ALDH1A1 (0.41) | MAPTALOX15SMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4728487-B2 | — | — | 2011-07-20 | — | — | JP | claimed |
| JP-2002539197-A | — | — | 2002-11-19 | — | — | JP | claimed |
| EP-1163219-A1 | SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS | CELGENE CORPORATION (US) | 2001-12-19 | — | — | EP | claimed |
| WO-2000055134-A1 | SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS | CELGENE CORPORATION (US) | 2000-09-21 | — | — | WO | claimed |
| US-6380239-B1 | FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA | CELGENE CORPORATION | 2002-04-30 | — | — | US | disclosed |
| EP-1163219-A1 | SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS | CELGENE CORPORATION (US) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000055134-A1 | SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS | CELGENE CORPORATION (US) | 2000-09-21 | — | — | WO | disclosed |